These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33562835)

  • 21. Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening.
    Yu ZH; Chen L; Wu L; Liu S; Wang L; Zhang ZY
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4238-42. PubMed ID: 21669525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Landscape of Protein Tyrosine Phosphatase (Shp2) and Cancer.
    Rehman AU; Rahman MU; Khan MT; Saud S; Liu H; Song D; Sultana P; Wadood A; Chen HF
    Curr Pharm Des; 2018; 24(32):3767-3777. PubMed ID: 30398108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
    Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; Fei F; Firestone B; Fodor M; Fridrich C; Gao H; Grunenfelder D; Hao HX; Jacob J; Ho S; Hsiao K; Kang ZB; Karki R; Kato M; Larrow J; La Bonte LR; Lenoir F; Liu G; Liu S; Majumdar D; Meyer MJ; Palermo M; Perez L; Pu M; Price E; Quinn C; Shakya S; Shultz MD; Slisz J; Venkatesan K; Wang P; Warmuth M; Williams S; Yang G; Yuan J; Zhang JH; Zhu P; Ramsey T; Keen NJ; Sellers WR; Stams T; Fortin PD
    Nature; 2016 Jul; 535(7610):148-52. PubMed ID: 27362227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marine alkaloid rigidin analogues as potential selective inhibitors of SHP1, a new strategy for cancer immunotherapeutics.
    Bhasin S; Das A
    J Biomol Struct Dyn; 2024 Jul; 42(11):5590-5606. PubMed ID: 37349914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.
    Vazhappilly CG; Saleh E; Ramadan W; Menon V; Al-Azawi AM; Tarazi H; Abdu-Allah H; El-Shorbagi AN; El-Awady R
    Invest New Drugs; 2019 Apr; 37(2):252-261. PubMed ID: 29947013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia.
    Pérez-Fernández A; López-Ruano G; Prieto-Bermejo R; Ijurko C; Díez-Campelo M; Sánchez-Guijo F; Hernández-Hernández Á
    J Exp Clin Cancer Res; 2019 Feb; 38(1):80. PubMed ID: 30764849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK.
    Yu M; Xu C; Zhang H; Lun J; Wang L; Zhang G; Fang J
    Biochem Biophys Res Commun; 2021 Jul; 563():1-7. PubMed ID: 34052504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application.
    Yuan X; Bu H; Zhou J; Yang CY; Zhang H
    J Med Chem; 2020 Oct; 63(20):11368-11396. PubMed ID: 32460492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2.
    Wu X; Xu G; Li X; Xu W; Li Q; Liu W; Kirby KA; Loh ML; Li J; Sarafianos SG; Qu CK
    J Med Chem; 2019 Feb; 62(3):1125-1137. PubMed ID: 30457860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SHP2 is a target of the immunosuppressant tautomycetin.
    Liu S; Yu Z; Yu X; Huang SX; Luo Y; Wu L; Shen W; Yang Z; Wang L; Gunawan AM; Chan RJ; Shen B; Zhang ZY
    Chem Biol; 2011 Jan; 18(1):101-10. PubMed ID: 21276943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates.
    Bone H; Dechert U; Jirik F; Schrader JW; Welham MJ
    J Biol Chem; 1997 May; 272(22):14470-6. PubMed ID: 9162089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells.
    Lee YJ; Song H; Yoon YJ; Park SJ; Kim SY; Cho Han D; Kwon BM
    Biochem Pharmacol; 2020 May; 175():113920. PubMed ID: 32201212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
    Hartman Z; Geldenhuys WJ; Agazie YM
    J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft.
    Lee MS; Yuet-Wa JC; Kong SK; Yu B; Eng-Choon VO; Nai-Ching HW; Chung-Wai TM; Fung KP
    Cancer Biol Ther; 2005 Nov; 4(11):1248-54. PubMed ID: 16258257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase.
    Rocchi S; Gaillard I; van Obberghen E; Chambaz EM; Vilgrain I
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):483-90. PubMed ID: 11085942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.
    Chen L; Pernazza D; Scott LM; Lawrence HR; Ren Y; Luo Y; Wu X; Sung SS; Guida WC; Sebti SM; Lawrence NJ; Wu J
    Biochem Pharmacol; 2010 Sep; 80(6):801-10. PubMed ID: 20510203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acids as natural specific inhibitors of the proto-oncogenic protein Shp2.
    Liu D; Kong G; Chen QC; Wang G; Li J; Xu Y; lin T; Tian Y; Zhang X; Yao X; Feng G; Lu Z; Chen H
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6833-7. PubMed ID: 21962577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A procedure combining molecular docking and semiempirical method PM7 for identification of selective Shp2 inhibitors.
    Rocha SFLS; Sant'Anna CMR
    Biopolymers; 2019 Nov; 110(11):e23320. PubMed ID: 31268558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors.
    Liu WS; Yang B; Wang RR; Li WY; Ma YC; Zhou L; Du S; Ma Y; Wang RL
    Bioorg Chem; 2020 Jul; 100():103875. PubMed ID: 32380342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure, function, and pathogenesis of SHP2 in developmental disorders and tumorigenesis.
    Huang WQ; Lin Q; Zhuang X; Cai LL; Ruan RS; Lu ZX; Tzeng CM
    Curr Cancer Drug Targets; 2014; 14(6):567-88. PubMed ID: 25039348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.